Association of TP53 mutation status with clinical outcomes stratified by sensitive and non sensitive EGFR mutation, in non-small cell lung cancer (NSCLC).
2015 ◽
Vol 33
(15_suppl)
◽
pp. e19076-e19076
Keyword(s):
2015 ◽
Keyword(s):
Keyword(s):
2018 ◽
Vol 6
(20)
◽
pp. 405-405
◽
Keyword(s):
2018 ◽
Vol 10
(7)
◽
pp. 4169-4177
◽
Keyword(s):
Keyword(s):
Keyword(s):
Keyword(s):
Keyword(s):
Keyword(s):